docetaxel,sotorasib
amgen
['nsclc', 'sotorasib', 'docetaxel', 'sclc']
randomized evaluation of ic activity of any #krasg12c inn, #sotorasib : reduced risk of progression in #cns recurrence vs docetaxel in pt with pretreated kras g12c mut dvanced #nsclc time to cns recurrence was 9.6 mo with sotorasib vs 5.4 mo in docetaxel 
Fellowship Program Director 👨‍🏫 Hematology & Oncology at George Washington University. Thoracic and Head&Neck cancer.